DE60325894D1 - Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten - Google Patents

Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten

Info

Publication number
DE60325894D1
DE60325894D1 DE60325894T DE60325894T DE60325894D1 DE 60325894 D1 DE60325894 D1 DE 60325894D1 DE 60325894 T DE60325894 T DE 60325894T DE 60325894 T DE60325894 T DE 60325894T DE 60325894 D1 DE60325894 D1 DE 60325894D1
Authority
DE
Germany
Prior art keywords
formula
lipase
preparation
compound
nucleoside analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325894T
Other languages
German (de)
English (en)
Inventor
Alex Cimpoia
James Joseph Lalonde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Application granted granted Critical
Publication of DE60325894D1 publication Critical patent/DE60325894D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60325894T 2002-11-18 2003-11-18 Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten Expired - Lifetime DE60325894D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42682102P 2002-11-18 2002-11-18
PCT/CA2003/001798 WO2004048590A1 (en) 2002-11-18 2003-11-18 Stereoselective process for the production of dioxolane nucleoside analogues

Publications (1)

Publication Number Publication Date
DE60325894D1 true DE60325894D1 (de) 2009-03-05

Family

ID=32393318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325894T Expired - Lifetime DE60325894D1 (de) 2002-11-18 2003-11-18 Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten

Country Status (9)

Country Link
US (1) US7955835B2 (ja)
EP (1) EP1573019B1 (ja)
JP (1) JP4501135B2 (ja)
AT (1) ATE420972T1 (ja)
AU (1) AU2003285230B2 (ja)
CA (1) CA2505552C (ja)
DE (1) DE60325894D1 (ja)
ES (1) ES2318179T3 (ja)
WO (1) WO2004048590A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085638A1 (en) * 2002-01-25 2005-04-21 Shire Biochem Inc Process for producing dioxolane nucleoside analogues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250842A (en) * 1991-02-22 1996-03-26 Univ Emory Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)
DK1140937T3 (da) 1998-12-23 2004-03-22 Shire Biochem Inc Antivirale nucleosid-analoger
AU2653200A (en) 1999-02-11 2000-08-29 Biochem Pharma Inc. Stereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
WO2004048590A1 (en) 2004-06-10
US7955835B2 (en) 2011-06-07
JP4501135B2 (ja) 2010-07-14
EP1573019B1 (en) 2009-01-14
AU2003285230A1 (en) 2004-06-18
CA2505552C (en) 2012-06-05
CA2505552A1 (en) 2004-06-10
JP2006506096A (ja) 2006-02-23
ATE420972T1 (de) 2009-01-15
US20060134763A1 (en) 2006-06-22
ES2318179T3 (es) 2009-05-01
AU2003285230B2 (en) 2010-04-22
EP1573019A1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
DE60238745D1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
ATE340857T1 (de) Verfahren zur herstellung von l-aminosäuren durch erhöhung des zellulären nadph
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
DE60326621D1 (de) Verfahren zur herstellung eines sputtertargets und sputtertarget
DK0629701T3 (da) Enzymatisk hydrolysemetode til fremstilling af C-10 og C-13 hydroxylbærende taxaner, enzymatisk esterificeringsmetode til f
ATE501264T1 (de) Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate
DE60322708D1 (de) Glucosesensor unter verwendung von glucosedehydrogenase
BR0307349A (pt) Processos para fermentar uma composição de fitoesterol e para preparar androestadienodiona a partir da androestenodiona, fusarium solani fmi 33, e, composição
KR100897457B1 (ko) 탁수스종의세포배양에의한탁산의생산증진방법
TW200619387A (en) Lipase powder composition and method for producing esterified product using the same
Jacobsen et al. Enantioselective enzymatic preparation of chiral glutaric monocarboxylic acids and amides
DE60325894D1 (de) Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten
ATE170924T1 (de) Verfahren zur veresterung von carbonsäuren mit tertiären alkoholen
NZ508404A (en) Alcoholic fermentation using a mineral-enriched yeast as a nutrient source
ATE386134T1 (de) Verfahren zur herstellung von glutathion
JP2769194B2 (ja) 酵素分解方法
EE05498B1 (et) Butnool-I-esteraas
ATE386132T1 (de) Verfahren zur enantioselektiven öffnung von 3- substituierten oxetan-2-onen unter verwendung der lipasen von candida antarctica oder von burkholderia plantarii
HUP9903899A2 (hu) Eljárás L-aminosavak fermentációs előállítására
CA2354382C (en) Process for preparing optically active 1-amino-4-(hydroxymethyl) cyclopent-2-ene derivatives
KR880701287A (ko) 광학적으로 활성인 1,2-디하이드로-3H-피롤로(1, 2a)피롤-1-카복실산 유도체의 제조방법
TW200639257A (en) Enzymatic synthesis method for a triglyceride of a phenylfatty acid
WO2004081220A3 (en) A process for enzymatically resolving an enantiomeric mixture of alpha-hydroxy acids
ATE211505T1 (de) Verfahren zur enzymatischen herstellung eines synthese-zwischenprodukt von befloxatone
ATE422552T1 (de) Verfahren zur enzymatischen reduktion von nad und nadp

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SHIRE CANADA INC., VILLE ST.-LAURENT, QUEBEC, CA

8364 No opposition during term of opposition